![Debora Barton](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Debora Barton
Director/Board Member at
American Cancer Society, Inc.
Net worth: 54 889 $ as of 31/08/2026
Profile
Debora Barton is currently the Director at American Cancer Society, Inc. since 2018.
Formerly, Dr. Barton was an Independent Non-Executive Director at Arovella Therapeutics Ltd. from 2021 to 2026, Senior VP, Head-Clinical & Safety at Iovance Biotherapeutics, Inc. from 2018 to 2019, Chief Medical Officer at CTx Operations, Inc. from 2019 to 2022, Chief Medical Officer at Carisma Therapeutics, Inc. from 2019 to 2022, and Chief Medical Officer at TScan Therapeutics, Inc. from 2022 to 2024.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 04/05/2026 | 1,276,490 ( 0.11% ) | 54 889 $ | 31/08/2026 |
Debora Barton active positions
| Companies | Position | Start |
|---|---|---|
American Cancer Society, Inc.
 American Cancer Society, Inc. Miscellaneous Commercial ServicesCommercial Services Operates voluntary health organization for cancer research | Director/Board Member | 01/05/2018 |
Former positions of Debora Barton
| Companies | Position | End |
|---|---|---|
| AROVELLA THERAPEUTICS LIMITED | Director/Board Member | 04/05/2026 |
| TSCAN THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 08/04/2024 |
CTx Operations, Inc.
 CTx Operations, Inc. BiotechnologyHealth Technology Develops macrophage-based immunotherapeutic for treatment of cancer | Chief Tech/Sci/R&D Officer | 01/06/2022 |
| CARISMA THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 01/06/2022 |
| IOVANCE BIOTHERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 01/11/2019 |
Training of Debora Barton
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
63
1st degree connections
7
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 7 |
|---|---|
Arovella Therapeutics Ltd.
 Arovella Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals and distributes medical devices and consumables | Health Technology |
American Cancer Society, Inc.
American Cancer Society, Inc. Miscellaneous Commercial ServicesCommercial Services Operates voluntary health organization for cancer research | Commercial Services |
Pontifícia Universidade Católica de São Paulo
 Pontifícia Universidade Católica de São Paulo Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Iovance Biotherapeutics, Inc.
 Iovance Biotherapeutics, Inc. BiotechnologyHealth Technology Develops biotechnological products for the treatment of cancer | Health Technology |
CTx Operations, Inc.
CTx Operations, Inc. BiotechnologyHealth Technology Develops macrophage-based immunotherapeutic for treatment of cancer | Health Technology |
TScan Therapeutics, Inc.
 TScan Therapeutics, Inc. BiotechnologyHealth Technology Develops T-cell therapies for cancer patients | Health Technology |
Carisma Therapeutics, Inc.
 Carisma Therapeutics, Inc. BiotechnologyHealth Technology Develops novel chimeric antigen receptor macrophage and CAR-monocyte technology treatment of non-muscle invasive bladder cancer | Health Technology |
- Stock Market
- Insiders
- Debora Barton
